This year’s National Council on AIDS (NCA) will redefine Nigeria’s HIV response strategy amid declining donor support and shifting global health priorities, Folakemi Animashaun, chief executive of ...

An HIV prevention pill that could provide a month of protection per tablet has been given the green light to proceed to pivotal trials to test its efficacy. Spotlight reports on new findings on the ...

When Robert Smith met his future girlfriend in 2010, he wanted to take things slowly. For Smith, no relationship had been ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

The UNAIDS annual report warns that Trump-era HIV funding cuts could lead to 6 million more infections and 4 million deaths by 2029 — as low-income countries struggle to fill the gap.

The UN warns millions will die by 2029 if US funding for HIV programs isn't replaced A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock ...

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

Health and Child Care minister Douglas Mombeshora, however, was quick to allay the fears saying the increase in HIV/Aids-related deaths was not related to funding cuts.

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...

Christian music artist Amy Grant performs to support PEPFAR, the global HIV/AIDS initiative facing budget cuts after saving 26 million lives worldwide.